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BACKGROUND: Epidemiological evidence on meat intake and breast cancer is inconsistent, with little research on potentially
carcinogenic meat-related exposures. We investigated meat subtypes, cooking practices, meat mutagens, iron, and subsequent breast
cancer risk.
METHODS: Among 52158 women (aged 55–74 years) in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, who
completed a food frequency questionnaire, 1205 invasive breast cancer cases were identified. We estimated meat mutagen and
haem iron intake with databases accounting for cooking practices. Using Cox proportional hazards regression, we calculated hazard
ratios (HRs) and 95% confidence intervals (CIs) within quintiles of intake.
RESULTS: Comparing the fifth to the first quintile, red meat (HR¼1.23; 95% CI¼1.00–1.51, P trend¼0.22), the heterocyclic amine
(HCA), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), (HR¼1.26; 95% CI¼1.03–1.55; P trend¼0.12), and dietary iron
(HR¼1.25; 95% CI¼1.02–1.52; P trend¼0.03) were positively associated with breast cancer. We observed elevated, though not
statistically significant, risks with processed meat, the HCA 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (DiMeIQx), mutagenic
activity, iron from meat, and haem iron from meat.
CONCLUSION: In this prospective study, red meat, MeIQx, and dietary iron elevated the risk of invasive breast cancer, but there was no
linear trend in the association except for dietary iron.
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Evidence of the role of meat intake in breast cancer is mixed. There
are conflicting findings from a pooled analysis of cohort studies
(Missmer et al, 2002), and a meta-analysis of cohort and case–
control studies (Boyd et al, 2003), yet several recent studies
indicate that meat may increase the risk of postmenopausal breast
cancer (Shannon et al, 2003; Steck et al, 2007; Taylor et al, 2007;
Egeberg et al, 2008; Hu et al, 2008); meat-related exposures
potentially involved, however, have not been well studied.
Meat mutagens, such as heterocyclic amines (HCAs) and
polycyclic aromatic hydrocarbons (PAHs), are formed in meat
cooked to well done at high temperatures (Sinha et al, 2005). Haem
iron, found mainly in red meat, is more bioavailable than non-
haem iron and, although iron homoeostasis is tightly controlled,
haem iron absorption is less well regulated (Carpenter and
Mahoney, 1992). Meat mutagens induce (el-Bayoumy et al, 1995;
Snyderwine et al, 2002) and iron promotes (Thompson et al, 1991;
Diwan et al, 1997) mammary carcinogenesis in rodent studies. Iron
may also be involved in breast cancer through interaction with
catechol oestrogen metabolites or production of hydroxyl radicals
(Liehr and Jones, 2001; Huang, 2003; Kabat and Rohan, 2007).
Limited epidemiological studies of meat mutagens (De Stefani
et al, 1997; Delfino et al, 2000; Sinha et al, 2000; Steck et al, 2007;
Sonestedt et al, 2008; Kabat et al, 2009; Mignone et al, 2009) and
haem iron (Lee et al, 2004; Kabat et al, 2007) are inconsistent.
We used unique databases and a detailed meat questionnaire to
comprehensively assess meat intake and potentially carcinogenic
meat-related exposures in relation to postmenopausal invasive
breast cancer in the prospective Prostate, Lung, Colorectal, and
Ovarian (PLCO) Cancer Screening Trial.
MATERIALS AND METHODS
The PLCO Cancer Screening Trial is a multi-center, randomised
controlled trial designed to evaluate screening methods for the
early detection of prostate, lung, colorectal, and ovarian cancer
(Prorok et al, 2000). Briefly, 154952 participants (78217 women),
aged 55–74 years, were recruited from 10 centres in the
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in the screened and non-screened arms of the trial completed a
self-administered baseline questionnaire on demographics,
personal/family cancer history, medical history, and lifestyle
habits. Starting in 1998, diet was assessed using the Diet History
Questionnaire (DHQ) (http://riskfactor.cancer.gov/DHQ/), the
National Cancer Institute’s (NCI) self-administered validated food
frequency questionnaire (FFQ) (Subar et al, 2001). Each year,
participants were sent annual study update questionnaires that
asked whether they had been diagnosed with cancer by a health
care provider. The study was approved by the institutional review
boards at the NCI and PLCO study centres. All participants
provided written informed consent.
Women were excluded from this analysis if they lacked the
baseline questionnaire (n¼2095) or the DHQ (n¼16886); missed
more than seven food items on the DHG (n¼1563); reported energy
intake in the top or bottom 1% of women (n¼1226); had a history
of cancer other than non-melanoma skin cancer before dietary
assessment (n¼6819); or no follow-up time (n¼1110). After
exclusions, with some subjects meeting multiple criteria, our
analytic cohort consisted of 52158 women. The vast majority of
the cohort was postmenopausal based on self-reported age at last
period and reason for last period. Menopausal status was ambiguous
for 1.7%, but 89.1% of the women with ambiguous data were 57 or
older, so the cohort was assumed to be postmenopausal.
Incident invasive breast cancer cases were identified through
self-report from the annual study update questionnaire, physician
reports, or through reports from the next of kin. This analysis
includes only histologically confirmed invasive breast cancers
based on pathology reports and medical records. Oestrogen
receptor (ER) and progesterone receptor (PR) data collection is
ongoing; we had receptor status for 388 of our cases. Entry date for
the analytic cohort was the latest of the following: randomisation,
completion of baseline questionnaire, or completion of the DHQ.
Follow-up ended on 31 December 2006, with breast cancer cases
exiting at the date of diagnosis and non-cases exiting at the date of
the most recent annual study update questionnaire without a
report of breast cancer.
The DHQ assessed usual intake (frequency and portion size) of 124
food items over the past year. Nutrient intake was estimated using the
Diet*Calc Analysis Program (version 1.4.3, National Cancer Institute,
Applied Research Program, 2005). Red meat (g per day) included
bacon, beef, cheeseburgers, cold cuts, ham, hamburgers, hot dogs,
liver, pork, sausage, veal, venison, and red meat from mixed dishes.
White meat included chicken, fish, and turkey. Processed meat
included bacon, cold cuts, ham, hot dogs, and sausage.
With the Computerised Heterocyclic Amines Resource for
Research in Epidemiology of Disease (CHARRED) (http://www.
charred.cancer.gov) software application and data from a detailed
meat-cooking module included in the DHQ, we generated intake
estimates of three HCAs (ng per day): 2-amino-3,4,8-trimethyl-
imidazo[4,5-f]quinoxaline (DiMeIQx), 2-amino-3,8-dimethylimidazo
[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenyl-imida-
zo[4,5-b]pyridine (PhIP), as well as benzo[a]pyrene (B[a]P), a marker
of total PAH exposure, and mutagenic activity in meat (revertant
colonies per day) (Sinha et al, 2005). We estimated haem iron from
meat using the NCI heme iron database based on the measured values
of haem iron from meat samples cooked by a range of methods to
varying doneness levels (Sinha et al,2 0 0 5 ) .T h eU n i t e dS t a t e s
Department of Agriculture (USDA, 2007) Survey Nutrient Database
was used to estimate iron from meat (limited to meats in the haem
iron database).
Statistical analysis
Hazard ratios (HRs) and 95% confidence intervals (CIs) were
estimated using Cox proportional hazards regression with age at
baseline as the underlying time metric; proportional hazards
assumptions were not violated. Quintile cut points for the dietary
exposures were based on intake in the analytic cohort, with the
lowest quintile as referent. Dietary variables, except the meat
mutagens, were energy adjusted using the multivariate nutrient
density method; residual adjustment did not alter our findings
(Willett, 1998). Tests for linear trend were based on median values
of each quintile. P-values are two-sided and analyses were
conducted using SAS (SAS Institute, Cary, NC, USA).
Multivariate models were adjusted for the following potential
confounders, which were selected because inclusion in the age-
adjusted model resulted in a 10% change in risk estimates, they
were associated with breast cancer in this dataset, or are
established breast cancer risk factors: age, race, education, study
centre, randomisation group, family history of breast cancer, age at
menarche, age at menopause (natural or surgical reasons), age at
first birth and number of live births, history of benign breast
disease, number of mammograms during past 3 years, menopausal
hormone therapy, body mass index (BMI), and intakes of alcohol,
total fat, and total energy. We included cross product terms in the
multivariate models to assess effect modification by alcohol intake,
parity, family history of breast cancer, BMI, menopausal hormone
therapy, and number of mammograms.
RESULTS
During a mean follow-up of 5.5 years, we identified 1205 invasive
breast cancer cases. Mean total meat intake was 62.9g per
1000kcal, with 29.5g per 1000kcal from red meat and 33.4g per
1000kcal from white meat. Women in the highest quintile of red
meat intake were slightly younger, less educated, and were less
likely to have a family history of breast cancer or more than
one mammogram in the past 3 years than those in the lowest
quintile (Table 1). Furthermore, women consuming the most
red meat were more likely to have a higher BMI, to have used
oral contraceptives, to be current smokers, and to have higher
energy and fat intakes. Similar patterns were seen for age, BMI,
oral contraceptives, and total energy intake comparing women in
the highest quintile of white meat intake to those in the lowest
quintile. In contrast, high white meat consumers were more
educated and less likely to be current smokers than those
consuming the least white meat.
We observed statistically significant or borderline-positive
associations between red meat and breast cancer starting in the
second quintile, and there was no evidence for a dose–response
effect (P trend¼0.22), consistent with a potential threshold effect
(Table 2). When we compared ER-positive/PR-positive tumours
(n¼259) to non-cases, the effect of red meat seemed to be stronger
(Q5 vs Q1 H¼1.59; 95% CI¼1.03–2.48; P trend¼0.09). There
were no statistically significant associations with processed meat,
white meat, or individual meat items.
Pan-fried meat, grilled meat, well/very well done meat, PhIP and
B[a]P were not associated with breast cancer (Table 3). There was
a borderline statistically significant increased risk for women
consuming the most meats that were cooked well or very well done
by pan-frying or grilling compared with those consuming the least.
Women in the highest quintile of MeIQx compared with those in
lowest had statistically significant elevated risks of breast cancer.
We also observed a marginally significant increased risk of breast
cancer for women with the highest intakes of DiMeIQx and
mutagenic activity; both associations had a statistically significant
linear trend.
Dietary iron was positively associated with breast cancer in a
dose–response manner, yet there was no association for total iron
or iron from supplements (Table 4). There were suggestive positive
associations with iron from meat and haem iron from meat, but
these relationships failed to reach statistical significance in the top
quintiles.
Dietary meat intake and breast cancer
LM Ferrucci et al
179
British Journal of Cancer (2009) 101(1), 178–184 & 2009 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yWe found some evidence of a stronger effect of red meat
(P interaction¼0.083), PhIP (0.014), mutagenic activity (0.010),
and haem iron (0.016) on breast cancer risk in women with BMI
o25 (469 cases) as opposed to those who were overweight (BMI
25–o30, 444 cases) or obese (BMI X30, 292 cases) (data not
shown). There was no effect modification by alcohol intake, parity,
family history of breast cancer, menopausal hormone therapy, or
number of mammograms.
Table 1 Means and proportions
a of baseline characteristics by red meat and white meat quintiles (n¼52158)
Quintile red meat Quintile white meat
Characteristic 1 3 5 1 3 5
Quintile mean (g per 1000kcal) 8.8 26.7 57.1 8.7 26.2 75.5
Age (years) 66.0 65.3 64.5 66.1 65.3 64.4
Race (%)
Non-Hispanic white 85.1 92.6 93.9 91.0 92.3 88.7
Non-Hispanic black 7.0 3.1 2.2 3.7 3.1 5.6
Hispanic 1.3 1.2 1.3 1.5 1.2 1.2
Asian 5.9 2.6 1.9 3.2 2.8 3.7
College graduate or postgraduate (%) 38.8 31.4 22.9 24.2 31.4 36.7
Family history of breast cancer (%) 14.1 14.1 13.6 14.1 13.8 13.7
History of benign breast disease (%) 28.7 28.6 26.7 26.0 28.4 30.4
Body mass index (kgm
 2) 25.7 27.1 28.4 26.8 27.1 27.4
Height (inches) 64.2 64.3 64.3 64.2 64.3 64.3
Age at menarche (years) (%)
o10 1.5 1.3 1.8 1.3 1.5 1.7
10–11 18.2 18.0 19.4 17.0 18.8 20.8
12–13 54.5 54.6 53.8 53.3 53.6 54.6
14–15 20.8 21.8 20.3 22.8 21.7 19.0
X16 4.8 4.2 4.5 5.5 4.2 3.9
Oral contraceptive use, ever (%) 51.9 55.7 58.8 51.6 55.6 60.0
Age at first birth (years) (%)
o19 13.4 16.0 18.9 18.5 16.0 14.8
20–24 44.0 47.9 49.9 46.7 48.1 47.1
25–29 23.1 20.0 17.4 18.6 20.4 21.4
X30 8.1 7.1 5.8 6.8 6.4 7.0
Parity (%)
Nulliparous 11.1 8.6 7.7 9.1 8.8 9.3
1 7.9 6.7 6.7 7.3 6.3 8.0
2 25.5 23.6 22.9 22.0 23.9 26.2
3 24.4 24.6 25.9 23.6 25.6 25.6
X4 31.0 36.3 36.7 37.9 35.3 30.9
41 mammogram in past 3 years (%) 74.8 73.6 69.5 68.2 73.5 76.7
Age at menopause (years) (%)
o40 13.3 13.2 14.4 14.7 13.4 13.6
40–44 13.2 14.2 14.7 14.5 13.7 12.9
45–49 23.7 23.5 22.8 23.6 23.4 23.2
50–54 38.1 36.2 36.5 35.9 37.0 38.0
X55 11.1 12.2 11.0 10.6 11.8 11.5
Menopausal hormone therapy (%)
Never 31.7 31.1 33.7 34.9 31.7 29.1
o1 year 11.6 11.2 10.6 11.3 11.1 11.7
1–5 years 19.4 19.3 18.6 17.6 18.8 20.7
6–9 years 12.1 13.0 12.9 10.9 13.3 14.3
X10 years 25.1 25.4 24.2 25.3 25.2 24.3
Smoking (%)
Never 59.2 58.5 54.3 59.4 57.8 53.6
Former 35.4 33.7 33.8 30.1 34.4 39.0
Current 5.4 7.8 11.9 10.5 7.8 7.4
Total caloric intake (kcal per day) 1476 1495 1547 1491 1481 1528
Total meat (g per 1000kcal) 44.0 59.2 90.8 34.2 58.0 103.7
Total fat (g per 1000kcal) 30.0 34.9 39.5 34.4 34.9 34.8
Alcohol (g per day) 4.7 5.4 4.7 4.6 5.2 5.0
aMay not sum to 100% due to missing data or rounding.
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In this prospective study, we observed positive associations
between red meat, MeIQx and dietary iron, and invasive post-
menopausal breast cancer. Only the dietary iron association was
statistically significant for linear trend, as the associations with red
meat and MeIQx were more consistent with a threshold effect
starting in the second quintile. We also found elevated, though not
statistically significant, risk of breast cancer with intakes of DiMeIQx,
mutagenic activity, iron from meat, and haem iron from meat.
Our results support an association between red meat and post-
menopausal breast cancer, and are similar to two other recent
prospective studies (Taylor et al, 2007; Egeberg et al,2 0 0 8 ) .O u r
finding of a potentially stronger effect of red meat among women
with ER-positive/PR-positive tumours is similar to results in pre-
menopausal women for adolescent (Linos et al, 2008) and recent (Cho
et al, 2006) red meat intake. However, epidemiological evidence on
red meat and breast cancer is mixed, with null results in four other
recent prospective studies (Holmes et al, 2003; van der Hel et al, 2004;
Kabat et al, 2007, 2009). It is not clear why prospective investigations
of meat and breast cancer have been inconsistent, as the potential
mechanisms underlying the association should not vary in different
populations. The variation could be in part due to the complexity of
assessing meat intake. Our observation of a potential threshold effect
is intriguing and may indicate that those consuming the least red
meat are different from other women.
Similar to some (Gertig et al, 1999; Delfino et al, 2000; Kabat
et al, 2009), but not all previous studies (De Stefani et al, 1997;
Zheng et al, 1998; Dai et al, 2002; Steck et al, 2007), we did not
observe a clear association with well/very well done and high
temperature cooked meats. Our finding for MeIQx is supported by
one previous case–control study (De Stefani et al, 1997); never-
theless, other studies of meat mutagens have been null (Delfino
et al, 2000; Steck et al, 2007; Sonestedt et al, 2008; Kabat et al, 2009;
Table 2 Distribution and HRs
a with 95% CIs for breast cancer risk according to quintiles of meat (g per 1000kcal)
Characteristic Q1 Q2 Q3 Q4 Q5 P trend
b
Red meat
Cases/Person-years 215/58396 280/57813 228/57651 239/57280 243/57108
Median (range) 9.4 (p14.6) 18.8 (414.6–22.8) 26.7 (422.8–31.0) 36.1 (431.0–42.5) 52.8 (442.5–196.3)
HR (95% CI) 1.00 1.32 (1.10–1.58) 1.09 (0.90–1.32) 1.16 (0.96–1.42) 1.23 (1.00–1.51) 0.22
Steak
Cases/Person-years 234/57950 239/58452 229/57570 261/57356 242/56921
Median (range) 0.0 (p0.6) 0.9 (40.6–1.2) 1.7 (41.2–2.4) 3.2 (42.4–4.7) 7.5 (44.7–131.3)
HR (95% CI) 1.00 0.94 (0.78–1.14) 0.89 (0.73–1.08) 1.01 (0.83–1.23) 0.95 (0.78–1.17) 0.82
Hamburger
Cases/Person-years 209/58291 269/57747 244/57809 255/57186 228/57215
Median (range) 0.3 (p0.6) 1.1 (40.6–1.6) 2.0 (41.6–2.7) 3.6 (42.7–4.9) 7.4 (44.9–98.8)
HR (95% CI) 1.00 1.28 (1.06–1.55) 1.13 (0.92–1.38) 1.22 (1.00–1.50) 1.10 (0.89–1.37) 0.84
Sausage
Cases/Person-years 251/63770 221/52321 232/58096 241/57370 260/56690
Median (range) 0.0 (p0.0) 0.1 (40.0–0.2) 0.3 (40.2–0.4) 0.7 (40.4–1.0) 1.7 (41.0–97.5)
HR (95% CI) 1.00 1.05 (0.87–1.26) 0.98 (0.82–1.19) 1.04 (0.86–1.26) 1.14 (0.94–1.39) 0.10
Bacon
Cases/Person-years 233/58521 253/58198 229/57649 237/57913 253/56687
Median (range) 0.0 (p0.1) 0.1 (40.1–0.2) 0.3 (40.2–0.4) 0.6 (40.4–1.0) 1.7 (41.0–46.2)
HR (95% CI) 1.00 1.06 (0.88–1.28) 0.95 (0.78–1.16) 0.99 (0.81–1.21) 1.07 (0.87–1.32) 0.38
Pork chops
Cases/Person-years 223/58109 242/57656 245/57695 255/57625 240/57163
Median (range) 0.1 (p0.4) 0.6 (40.4–0.9) 1.2 (40.9–1.6) 2.1 (41.6–3.0) 4.5 (43.0–74.2)
HR (95% CI) 1.00 1.03 (0.86–1.25) 1.01 (0.83–1.23) 1.06 (0.86–1.29) 0.99 (0.80–1.22) 0.94
White meat
Cases/Person-years 223/57645 246/57909 261/57593 236/57727 239/57375
Median (range) 9.2 (p13.4) 17.4 (413.4–21.5) 26.1 (421.5–31.4) 38.6 (431.4–49.1) 66.9 (449.1–313.6)
HR (95% CI) 1.00 1.06 (0.88–1.27) 1.11 (0.93–1.33) 0.99 (0.82–1.19) 1.01 (0.84–1.22) 0.70
Chicken
Cases/Person-years 235/57630 243/57859 244/57877 249/57445 234/57437
Median (range) 3.6 (p6.0) 8.4 (46.0–11.2) 14.4 (411.2–18.3) 23.7 (418.3–32.5) 48.8 (432.5–261.8)
HR (95% CI) 1.00 0.98 (0.81–1.18) 0.96 (0.80–1.16) 0.98 (0.81–1.18) 0.93 (0.77–1.13) 0.52
Fish
Cases/Person-years 218/57510 248/57769 249/57551 241/57925 249/57494
Median (range) 1.8 (p3.1) 4.2 (43.1–5.4) 6.8 (45.4–8.5) 10.6 (48.5–14.0) 20.4 (414.0–229.4)
HR (95% CI) 1.00 1.10 (0.92–1.33) 1.09 (0.90–1.31) 1.04 (0.86–1.26) 1.08 (0.89–1.31) 0.76
Processed meat
Cases/Person-years 218/58209 250/57934 251/57597 255/57278 231/57230
Median (range) 1.4 (p2.4) 3.4 (42.4–4.3) 5.5 (44.3–6.9) 8.7 (46.9–11.6) 16.9 (411.6–124.1)
HR (95% CI) 1.00 1.17 (0.98–1.41) 1.20 (0.99–1.45) 1.23 (1.02–1.49) 1.12 (0.92–1.36) 0.66
Abbreviations: CI¼confidence interval; HR¼hazard ratio; Q¼quintile.
aAdjusted for age (continuous), race (non-Hispanic white, non-Hispanic black, Hispanic, Asian, other),
education (p11 years, 12 years or high school graduate, post high school training, some college, college graduate or postgraduate education, missing), study centre,
randomisation group, family history of breast cancer (yes, no, missing), age at menarche (o10, 10–11, 12–13, 14–15, X16 years, missing), age at menopause (o40, 40–44,
45–49, 50–54, X55 years, missing), age at first birth and number of live births (nulliparous; o20 years and 1, 2, or X3 births; 20–29 years and 1, 2, or X3 births; X30 years
and 1, 2, or X3 births; missing), history of benign breast disease (yes, no, missing), number of mammograms during past 3 years (0, 1, 41, missing), menopausal hormone therapy
use (never, p1, 2–5, 6–9, X10 years), body mass index (18.5–24.9, 25–29.9, X30kgm
 2), alcohol intake (o5, 5–14.9, X15g per day), total fat intake (continuous, g per
1000kcal), and total energy intake (continuous, kcal per day).
bP trend calculated using the median of each quintile.
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Egeberg et al, 2008) or well-done meat (Zheng et al, 1999;
Deitz et al, 2000) and xenobiotic-metabolising gene variants might
explain these contradictory findings.
Epidemiological studies of iron and breast cancer are also
mixed. Three case–control studies of dietary iron (Levi et al, 2001;
Adzersen et al, 2003; Kallianpur et al, 2008) have been null, yet two
others have found inverse associations (Negri et al, 1996; Cade
et al, 1998). One cohort study reported positive associations for
both dietary iron and haem iron among high alcohol consumers
(Lee et al, 2004), yet another cohort found no association with
either exposure regardless of alcohol intake (Kabat et al, 2007).
Future research may need to evaluate the role of genes involved in
iron absorption or oxidative stress, as breast cancer risk may differ
by certain gene variants (Kallianpur et al, 2004; Hong et al, 2007).
Our results for haem iron may vary from earlier research (Lee
et al, 2004; Kabat et al, 2007) that calculated haem iron as standard
proportions of total iron from meat (Monsen and Balintfy, 1982;
Balder et al, 2006), as we estimated haem iron based on measured
values from meat samples. The pattern of risk that we observed for
haem iron was similar to that for red meat. As these measures are
highly correlated (r¼0.77) they cannot be evaluated in the same
model, making it difficult to determine whether the risk can be
attributed to this individual component. However, individuals
were not always ranked in the same quintile of the two exposures
(weighted Kappa¼0.59), indicating that haem iron may not just be
a surrogate for red meat.
Strengths of this analysis include the detailed prospective data
and investigation of specific meat-related exposures with separate,
plausible pathways for influencing breast carcinogenesis. Although
there is inherent measurement error in FFQs, this typically results
in attenuation of risks. To minimise this error, our models
included total energy intake. However, our ability to detect
small associations may still be limited. The diet was assessed
only once and this may not have been the time period most
relevant to neoplasia. We also had limited ability to evaluate
Table 3 Distribution and HRs
a with 95% CIs for breast cancer risk according to quintiles of cooking method, doneness level, and meat mutagens
Characteristic Q1 Q2 Q3 Q4 Q5 P trend
b
Cooking method and doneness
Pan-fried meat
Cases/Person-years 233/56615 243/57881 248/57319 245/57316 235/57245
Median (range) (g per 1000kcal) 0.1 (p0.4) 0.7 (40.4–1.1) 1.7 (41.1–2.4) 3.4 (42.4–5.0) 8.1 (45.0–77.1)
HR (95% CI) 1.00 1.01 (0.84–1.21) 1.05 (0.87–1.27) 1.04 (0.85–1.27) 1.03 (0.84–1.27) 0.76
Grilled meat
Cases/Person-years 222/56653 246/58049 252/57887 236/57289 248/56498
Median (range) (g per 1000kcal) 0.1 (p0.7) 1.2 (40.7–1.9) 2.8 (41.9–3.9) 5.4 (43.9–7.6) 11.9 (47.6–161.1)
HR (95% CI) 1.00 1.07 (0.89–1.29) 1.09 (0.90–1.31) 1.02 (0.84–1.24) 1.10 (0.90–1.34) 0.54
Well/very well done meat
Cases/Person-years 235/56101 235/57952 239/57865 236/57662 259/56796
Median (range) (g per 1000kcal) 1.9 (p3.2) 4.4 (43.2–5.7) 7.1 (45.7–8.9) 11.1 (48.9–14.3) 20.2 (414.3–158.8)
HR (95% CI) 1.00 0.94 (0.78–1.13) 0.96 (0.79–1.15) 0.95 (0.78–1.15) 1.09 (0.90–1.32) 0.17
Grilled/pan fried well/very well done meat
Cases/Person-years 227/56511 250/58079 249/57823 215/57470 263/57493
Median (range) (g per 1000kcal) 0.3 (p0.9) 1.5 (40.9–2.3) 3.1 (42.3–4.2) 5.7 (44.2–7.7) 11.6 (47.7–158.8)
HR (95% CI) 1.00 1.07 (0.89–1.29) 1.07 (0.89–1.29) 0.94 (0.77–1.14) 1.20 (0.99–1.45) 0.10
Meat mutagens
DiMeIQx
Cases/Person-years 236/58051 236/57899 227/57868 245/57303 261/57127
Median (range) (ng per day) 0.0 (p0.1) 0.2 (40.1–0.3) 0.5 (40.3–0.7) 1.0 (40.7–1.6) 2.5 (41.6–76.2)
HR (95% CI) 1.00 1.03 (0.86–1.24) 0.99 (0.83–1.20) 1.08 (0.90–1.30) 1.18 (0.98–1.42) 0.04
MeIQx
Cases/Person-years 220/58585 255/58100 245/57333 241/57223 244/57007
Median (range) (ng per day) 1.5 (p2.8) 4.2 (42.8–5.7) 7.6 (45.7–10.0) 13.3 (410.0–18.2) 27.8 (418.2–516.2)
HR (95% CI) 1.00 1.20 (1.00–1.43) 1.18 (0.98–1.43) 1.17 (0.97–1.42) 1.26 (1.03–1.55) 0.12
PhIP
Cases/Person-years 238/58305 224/57940 255/57611 235/57528 253/56865
Median (range) (ng per day) 3.7 (p7.6) 12.5 (47.6–18.7) 25.9 (418.7–36.8) 51.0 (436.8–75.2) 121.1 (475.2–3178.8)
HR (95% CI) 1.00 0.95 (0.79–1.15) 1.09 (0.91–1.31) 1.00 (0.83–1.21) 1.11 (0.92–1.34) 0.22
B[a]P
Cases/Person-years 234/58269 257/58144 244/57638 244/57278 226/56918
Median (range) (ng per day) 0.5 (p1.3) 2.2 (41.3–3.7) 5.4 (43.7–7.4) 11.9 (47.4–16.7) 29.9 (416.7–697.7)
HR (95% CI) 1.00 1.11 (0.93–1.33) 1.08 (0.90–1.30) 1.08 (0.90–1.30) 1.01 (0.83–1.23) 0.59
Mutagenic activity
Cases/Person-years 231/58649 241/57870 212/57517 274/57358 247/56854
Median (range) (revertant
colonies per day)
235 (p448) 672 (4448–925) 1247 (4925–1640) 2205 (41640–3031) 4691 (43031–225039)
HR (95% CI) 1.00 1.08 (0.90–1.30) 0.96 (0.80–1.17) 1.26 (1.05–1.52) 1.18 (0.97–1.44) 0.05
Abbreviations: B[a]P¼benzo[a]pyrene; CI¼confidence interval; DiMeIQx¼2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline; HR¼hazard ratio; MeIQx¼2-amino-3,8-
dimethylimidazo[4,5-f]quinoxaline; PhIP¼2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine; Q¼quintile.
aAdjusted for age (continuous), race (non-Hispanic white, non-
Hispanic black, Hispanic, Asian, other), education (p11 years, 12 years or high school graduate, post high school training, some college, college graduate or postgraduate
education, missing), study centre, randomisation group, family history of breast cancer (yes, no, missing), age at menarche (o10, 10–11, 12–13, 14–15, X16 years, missing), age
at menopause (o40, 40–44, 45–49, 50–54, X55 years, missing), age at first birth and number of live births (nulliparous; o20 years and 1, 2, or X3 births; 20–29 years and 1,
2, or X3 births; X30 years and 1, 2, or X3 births; missing), history of benign breast disease (yes, no, missing), number of mammograms during past 3 years (0, 1, 41, missing),
menopausal hormone therapy use (never, p1, 2–5, 6–9, X10 years), body mass index (18.5–24.9, 25–29.9, X30kgm
 2), alcohol intake (o5, 5–14.9, X15g per day), total
fat intake (continuous, g per 1000kcal), and total energy intake (continuous, kcal per day).
bP trend calculated using the median of each quintile.
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ytumour sub-types, as our results were based on ongoing and
therefore incomplete ascertainment. Finally, the observed associa-
tions could be due to unmeasured confounding, although we
investigated many potential confounders.
Overall, the epidemiological evidence for meat in relation to
breast cancer remains inconclusive; however, with few known
modifiable risk factors, this dietary component should be further
investigated. Our results regarding meat mutagens and haem iron
indicate a need to evaluate multiple meat-related exposures in
relation to breast carcinogenesis.
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